← back to search

Takashi Kadowaki

Oasis Hospital · JP
🔎 Find collaborators in Endocrinology, Diabetes and Metabolism · Epidemiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Endocrinology, Diabetes and Metabolism · Epidemiology
Research interest
Research interests include Diabetes Treatment and Management, Adipokines, Inflammation, and Metabolic Diseases, Pancreatic function and diabetes, and Adipose Tissue and Metabolism.
h-index
153
citations
111,892
works
1,361
NIH funding
primary concept
email

Recent publications

A cross-population compendium of gene-environment interactions.
2026cited by 1position: contributordoi
Definition and diagnostic criteria of clinical obesity
The Lancet Diabetes & Endocrinology 2025cited by 1,179position: middledoi
Definition and diagnostic criteria of clinical obesity.
2025cited by 863position: contributordoi
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
2025cited by 58position: contributordoi
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
2025cited by 14position: contributordoi
Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
2025cited by 13position: contributordoi
Physiological and pathophysiological actions of insulin in the liver.
2025cited by 9position: contributordoi
Female sex hormones inversely regulate acute kidney disease susceptibility throughout life.
2025cited by 8position: contributordoi
Cross-sectional and Longitudinal Associations Between Family History of Type 2 Diabetes Mellitus, Hypertension, and Dyslipidemia and Their Prevalence and Incidence: Toranomon Hospital Health Management Center Study (TOPICS24).
2025cited by 3position: contributordoi
Refractory phenotype of <i>Aspergillus</i>-sensitized asthma with bronchiectasis and allergic bronchopulmonary aspergillosis.
2025cited by 3position: contributordoi
Effect of once-weekly subcutaneous semaglutide on abdominal visceral fat area in Japanese adults with overweight and obesity: A post hoc analysis of the STEP 6 trial.
2025cited by 2position: contributordoi
Genetic studies on metabolic disorder-associated kidney diseases.
2025cited by 2position: contributordoi
Activin B improves glucose metabolism via induction of Fgf21 and hepatic glucagon resistance.
2025cited by 2position: contributordoi
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
2025cited by 2position: contributordoi
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial.
2025cited by 1position: contributordoi
Whole-genome sequencing reveals rare and structural variants contributing to psoriasis and identifies CERCAM as a risk gene.
2025cited by 1position: contributordoi
Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study.
2025cited by 1position: contributordoi
Relative survival among cancer survivors enrolled in private cancer insurance in Japan, using the internal insurance-enrolled population as the reference.
2025cited by 1position: contributordoi
Dissociating the metabolic and tumor-suppressive activity of p53.
2025cited by 1position: contributordoi
Adherence to physician visits for diabetes care and cardiovascular disease risk: A retrospective cohort study using an administrative claims database.
2025cited by 1position: contributordoi
Temporal trends in time toxicity of R-CHOP: a nationwide hospital-based database analysis in Japan.
2025cited by 1position: contributordoi
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.
2025cited by 1position: contributordoi
Dissecting cross-population polygenic heterogeneity across respiratory and cardiometabolic diseases.
2025cited by 1position: contributordoi
Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes: The OASIS 2 Randomized Clinical Trial.
2025cited by 0position: contributordoi
Preoperative rehabilitation and in-hospital mortality in delayed hip fracture surgery: a nationwide cohort study with stratification by kidney function.
2025cited by 0position: contributordoi
Association between tinea pedis and foot care factors in patients with diabetes.
2025cited by 0position: contributordoi
Impact of the COVID-19 Pandemic on Health Check-ups before and after the COVID-19 Downgrade and Employees' Mental Health at Health Check-up Facilities: The Third Nationwide Survey of Healthcare Facilities in Japan Society of Ningen Dock and Preventive Medical Care.
2025cited by 0position: contributordoi
Effects of rapid weight loss on the body composition and pathophysiological mechanisms involved in obesity.
2025cited by 0position: contributordoi
Children Comorbidity Score, a Simple Predictor for In-hospital Mortality: A Nationwide Inpatient Database Study in Japan.
2025cited by 0position: contributordoi
Steatotic liver index: An interpretable predictor of steatotic liver disease using machine learning with an enhanced shrinkage method.
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 40 papers (2019–2026)Toshimasa Yamauchi · Toranomon Hospital20 papers (2019–2026)Masaomi Nangaku · Saitama Medical University13 papers (2019–2025)Yukinori Okada · Osaka University Graduate School of Medicine11 papers (2019–2026)Naoto Kubota · The University of Texas Southwestern Medical Center10 papers (2020–2024)Jonathan R Emberson · Manchester University NHS Foundation Trust8 papers (2022–2025)Katherine R. Tuttle · University of Colorado Denver8 papers (2022–2025)Satoko Yamaguchi · Showa University Hospital8 papers (2019–2025)Ken Suzuki · The Institute of Statistical Mathematics7 papers (2019–2026)Sachiko Ono · Chiba Cancer Center7 papers (2020–2025)Aldo P. Maggioni · Policlinico Umberto I6 papers (2022–2025)Xavier Rossello · University of Manitoba6 papers (2023–2025)Koichi Matsuda · The University of Tokyo6 papers (2019–2026)Takayoshi Sasako · Diabetes Australia6 papers (2019–2025)Bernhard Banas · University of Regensburg6 papers (2023–2025)Kohjiro Ueki · Institute for Security Studies5 papers (2021–2025)Hirotaka Watada · National Center for Geriatrics and Gerontology5 papers (2021–2024)Yutaka Seino · Niigata University Medical and Dental Hospital5 papers (2020–2025)Federico Alberici · Surgical Specialties (United States)5 papers (2023–2025)Kyuto Sonehara · Nagoya University5 papers (2024–2026)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Endocrinology, Diabetes and Metabolism · Epidemiology →